• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Booster immunisation for diphtheria and tetanus: no evidence of need in adults.

作者信息

Mathias R G, Schechter M T

出版信息

Lancet. 1985 May 11;1(8437):1089-91. doi: 10.1016/s0140-6736(85)92383-9.

DOI:10.1016/s0140-6736(85)92383-9
PMID:2860299
Abstract

Recommendations to give adults diphtheria and tetanus toxoid every ten years have been based on serological surveys that have shown lower antibody levels in older populations. The purpose of an immunisation programme, however, is to prevent disease and not merely to produce antibodies. In Canada, although an immunisation programme against diphtheria has been in operation for nearly sixty years, age-specific morbidity and mortality rates for diphtheria do not show an increase with age. Similarly, age-specific death rates from tetanus do not show any increase. From Canadian surveillance data, there is no evidence to suggest that people are leaving the immune pool and entering the susceptible pool. Immunisation programmes do not need to include routine administration of booster doses of diphtheria and tetanus toxoids to adults since the benefits of the procedure do not justify the risks or costs. Continuing case-surveillance will bring to light any increase in incidence of disease justifying a need for an adult programme.

摘要

相似文献

1
Booster immunisation for diphtheria and tetanus: no evidence of need in adults.
Lancet. 1985 May 11;1(8437):1089-91. doi: 10.1016/s0140-6736(85)92383-9.
2
Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).预防青少年破伤风、白喉和百日咳:破伤风类毒素、白喉类毒素含量降低的无细胞百日咳疫苗的使用——免疫实践咨询委员会(ACIP)的建议
MMWR Recomm Rep. 2006 Mar 24;55(RR-3):1-34.
3
Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel.预防成人破伤风、白喉和百日咳:免疫实践咨询委员会(ACIP)关于使用破伤风类毒素、吸附白喉类毒素和无细胞百日咳疫苗的建议,以及在医疗感染控制实践咨询委员会(HICPAC)支持下,ACIP关于医护人员使用破伤风类毒素、低剂量白喉类毒素和无细胞百日咳疫苗(Tdap)的建议。
MMWR Recomm Rep. 2006 Dec 15;55(RR-17):1-37.
4
Tdap5 vaccine (Covaxis): a review of its use as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis in children (aged 4 years), adolescents, and adults.Tdap5 疫苗(Covaxis):作为一种单剂疫苗,用于预防儿童(4 岁)、青少年和成人破伤风、白喉和百日咳的用途综述。
BioDrugs. 2010 Dec 1;24(6):387-406. doi: 10.2165/11206000-000000000-00000.
5
High tetanus and diphtheria antitoxin concentrations in Finnish adults--time for new booster recommendations?芬兰成年人破伤风和白喉抗毒素浓度较高——是时候提出新的加强免疫建议了吗?
Vaccine. 2009 Aug 27;27(39):5295-8. doi: 10.1016/j.vaccine.2009.06.080. Epub 2009 Jul 9.
6
Immunisation of adults during an outbreak of diphtheria.白喉暴发期间成人的免疫接种。
Br Med J (Clin Res Ed). 1983 Feb 19;286(6365):624-6. doi: 10.1136/bmj.286.6365.624.
7
Combined, reduced-antigen content tetanus, diphtheria, and acellular pertussis vaccine (Boostrix): a review of its use as a single-dose booster immunization in individuals aged 10-64 years in the US.含低剂量抗原的破伤风、白喉和无细胞百日咳联合疫苗(Boostrix):在美国,10-64 岁人群中作为单剂加强免疫接种的使用评价。
BioDrugs. 2009;23(4):253-67. doi: 10.2165/11202770-000000000-00000.
8
Adult vaccination against tetanus and diphtheria: the European perspective.成人破伤风和白喉疫苗接种:欧洲视角
Clin Exp Immunol. 2017 Jan;187(1):93-99. doi: 10.1111/cei.12822. Epub 2016 Jul 12.
9
Primary immunization with tetanus and diphtheria toxoids. Reaction rates and immunogenicity in older children and adults.
JAMA. 1982 Nov 19;248(19):2478-80.
10
Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first booster in adolescence: An open, phase III, non-randomized, multi-center study.青少年首针加强免疫 10 年后接种含低含量抗原白喉破伤风联合无细胞百日咳疫苗的二价加强免疫的免疫原性和安全性:一项开放、III 期、非随机、多中心研究。
Hum Vaccin Immunother. 2018;14(8):1977-1986. doi: 10.1080/21645515.2018.1460292. Epub 2018 May 10.

引用本文的文献

1
Decennial diphtheria-tetanus adult boosters: are they really necessary?十年一次的成人白喉-破伤风加强疫苗接种:真的有必要吗?
J Prev Med Hyg. 2015 Jun 10;56(1):E44-8.
2
Immunity to diphtheria in a sample of the Canadian adult population.加拿大成年人群样本对白喉的免疫力。
Can J Infect Dis. 1998 Nov;9(6):367-71. doi: 10.1155/1998/690372.
3
Levels of diphtheria and tetanus specific IgG of Portuguese adult women, before and after vaccination with adult type Td. Duration of immunity following vaccination.葡萄牙成年女性接种成人型白百破疫苗前后白喉和破伤风特异性IgG水平。接种疫苗后的免疫持续时间。
BMC Public Health. 2007 Jun 12;7:109. doi: 10.1186/1471-2458-7-109.
4
Diphtheria immunity in Flanders.法兰德斯地区的白喉免疫力。
Eur J Clin Microbiol Infect Dis. 1997 Sep;16(9):631-6. doi: 10.1007/BF01708551.
5
Diphtheria: epidemiological update and review of prevention and control strategies.白喉:流行病学最新情况及预防与控制策略综述
Eur J Epidemiol. 1997 Jul;13(5):527-34. doi: 10.1023/a:1007305205763.
6
Prevalence of hyperimmunization against tetanus in Italians born after the introduction of mandatory vaccination of children with tetanus toxoid in 1968.
Infection. 1993 Mar-Apr;21(2):80-2. doi: 10.1007/BF01710736.
7
Tetanus immunization: concerns about the elderly and about diphtheria reemergence.破伤风免疫:对老年人及白喉再度出现的担忧。
J Gen Intern Med. 1994 Feb;9(2):117; author reply 118.
8
Long-term persistence of anti-diphtheria toxin antibodies among adults in Israel. Implications for vaccine policy.以色列成年人中抗白喉毒素抗体的长期持久性。对疫苗政策的影响。
Eur J Epidemiol. 1994 Jun;10(3):267-70. doi: 10.1007/BF01719348.
9
Efficiency and effectiveness.效率与效果。
Arch Emerg Med. 1985 Sep;2(3):109-12. doi: 10.1136/emj.2.3.109.
10
Detection of diphtheria toxin antibodies in human sera in New Zealand by ELISA.采用酶联免疫吸附测定法检测新西兰人血清中的白喉毒素抗体。
J Hyg (Lond). 1986 Jun;96(3):415-8. doi: 10.1017/s0022172400066171.